Skip to main content

Main menu

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • RESOURCES
    • About BJGP
    • Conference
    • Advertising
    • BJGP Life
    • eLetters
    • Librarian information
    • Alerts
    • Resilience
    • Video
    • Audio
    • COVID-19 Clinical Solutions
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
    • RCGP e-Portfolio

User menu

  • Subscriptions
  • Alerts
  • Log in

Search

  • Advanced search
British Journal of General Practice
  • RCGP
    • BJGP for RCGP members
    • BJGP Open
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
    • RCGP e-Portfolio
  • Subscriptions
  • Alerts
  • Log in
  • Follow bjgp on Twitter
  • Visit bjgp on Facebook
  • Blog
  • Listen to BJGP podcast
Advertisement
British Journal of General Practice

Advanced Search

  • HOME
  • ONLINE FIRST
  • CURRENT ISSUE
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • SUBSCRIBE
  • RESOURCES
    • About BJGP
    • Conference
    • Advertising
    • BJGP Life
    • eLetters
    • Librarian information
    • Alerts
    • Resilience
    • Video
    • Audio
    • COVID-19 Clinical Solutions
Editorials

The predictive value of cancer symptoms in primary care

Kevin Barraclough
British Journal of General Practice 2010; 60 (578): 639-640. DOI: https://doi.org/10.3399/bjgp10X515304
Kevin Barraclough
Stroud
Roles: GP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info
  • eLetters
  • PDF
Loading

GPs are presented, several times a day, with patients with a mass of intertwined symptoms. Many of these symptoms, often matted together like overcooked pasta, could be due to cancer. In practice most of them are not. However, neither GPs nor specialists have the experience to weight these symptoms accurately: GPs because they do not see enough patients with individual cancers, and specialists because they do not see enough patients who are healthy (leading to ‘spectrum bias’1). For this reason ‘gut feeling’, instinct, or previous experience are all relatively blunt discriminators. Secondary care studies are also of limited use. What we really need are numbers from good primary care studies. These are surprisingly few and far between.2,3

Shapley et al3 analysed all high-quality primary care studies that identify clinical features that have, in at least one age/sex range, a positive predictive value (PPV) of 5% or more. In justifying their 5% figure they discuss what level of cancer risk should routinely be investigated.

The authors identify eight clinical features that predict cancer at the 5% probability level: rectal bleeding, change in bowel habit, iron deficiency anaemia, macroscopic haematuria, a malignant-feeling prostate on rectal examination, breast lumps, and post menopausal bleeding. Unsurprisingly, age ranges are critical to PPV: iron deficiency anaemia in a 21-year-old female is extremely unlikely to be due to colorectal cancer whereas in a 60-year-old male cancer is likely. ‘Change in bowel habit’ is the only feature that obviously involves a subjective judgment by the doctor.2

The authors argue that, with a 5% absolute risk of cancer, ‘exclusion of cancer is obligatory unless exceptional circumstances exist’. They compare this level of cancer risk with the 5% reduction in 10 year cardiovascular risk expected for primary prevention with statins in individuals with a Framingham risk score of 20%.

This is a useful ‘back of the envelope’ calculation. Quantifying absolute benefit is essential in assessing treatments. Quantifying absolute risk is also well developed in cardiovascular medicine. Yet quantifying absolute risk is a relative latecomer to the debate about cancer diagnosis. We often give patients numbers to enable them to make informed decisions about cardiovascular risk, but we rarely do so with cancer. How many women would have lifetime cervical smears if they knew that their chance of avoiding death is about 1 in 1000, while the chance of them having a cone biopsy is about 1 in 12?4

However, the authors' analysis clearly raises many questions that need more detailed analysis and debate: surely avoiding a 1% absolute risk in a 35 year old is at least as beneficial as a 10% risk avoided in a 65 year old. Is it as beneficial detecting a lung cancer (often incurable) as detecting a colorectal cancer (often curable); is there a net benefit with early detection of prostate cancer; and where do the patients' own views come into all of this?

What we actually want (as a minimum) are three bits of information: the PPV, the number needed to treat to save a life with early cancer treatment, and some assessment similar to a ‘quality-adjusted life year’ (QALY) for the whole process.

There are various reasons why these data are required fairly urgently. The obvious reason is that patients may be dying unnecessarily if we, as GPs, are initiating referral or investigation at too high a level of risk. The second reason is that inappropriate intervention at too low a level of risk is also harmful. As with randomised controlled trials, there is an asymmetry between the ease of detecting harm and detecting benefit.5 Trials potentially measure the large benefit to the few patients who are diagnosed early and treated. They rarely measure the significant low level of harm to the large majority who are fruitlessly investigated. As GPs we are very aware of the risk of ‘medicalising’ people's lives and the potential cascade effect of over investigation.6

The last imperative is, I think, less well recognised. Referral guidance potentially has significant litigation costs associated with it if it is over inclusive. Much of the current National Institute for Health and Clinical Excellence referral guidance has been shown to have a sound evidence base.7 However, some has little supporting data and is potentially problematic.

A GP may currently have difficulty justifying a failure to refer urgently a 60-year-old male with a single prostate-specific antigen (PSA) of 6 (yet 10% of males aged 50–70 years have a raised PSA), or microscopic haematuria in a 60-year-old female (yet reported prevalence rates are up to 16.1%8). The litigation bill for the NHS for delayed diagnosis of cancer is significant, and better data should help to make guidelines more robust and justifiable.

As virtually all cancer diagnoses start in primary care, it remains surprising that so little research is directed at this area. It would be very useful to repeat the methods of Shapley et al and identify current research that identifies clinical features with PPVs in the range of 1% to 5% and <1%.

The two most common methodologies for symptom-based research reviewed in this paper are retrospective cohort studies using clinical databases, such as the General Practice Research Database7 and primary care case control studies.9 Both methods are efficient and fruitful (although the retrospective cohort study may suffer from selective recording of symptoms in those referred with suspected cancer which erroneously elevates the measured PPV). It would also be useful to investigate whether there is a difference in PPV between volunteered symptoms (for example, volunteered dysphagia symptoms: ‘My food sticks’) and elicited symptoms (‘Does your food stick?’, ‘Yes, a bit.’).

Shapley et al's paper is very useful but it does highlight the pressing need for an explicit agenda for symptom-based research in primary care to inform cancer referral guidelines.

Notes

Provenance

Commissioned; not peer reviewed.

  • © British Journal of General Practice, 2010.

REFERENCES

  1. ↵
    1. Jelinek M
    (2008) Spectrum bias: why generalists and specialists do not connect. Evid Based Med 13(5):132–133.
    OpenUrlFREE Full Text
  2. ↵
    1. Hamilton W
    (2010) Cancer diagnosis in primary care. Br J Gen Pract 60(571):121–128.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Shapley M,
    2. Mansell G,
    3. Jordan JL,
    4. Jordan KP
    (2010) Positive predictive values of ≥5% in primary care for cancer: systematic review. Br J Gen Pract, 10.3399/bjgp10X515412.
  4. ↵
    1. Raffle AE,
    2. Alden B,
    3. Quinn M,
    4. et al.
    (2003) Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. BMJ 326:901.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Kent DM,
    2. Hayward RA
    (2007) Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA 298(10):1209–1212.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Deyo RA
    (2002) Cascade effects of medical technology. Annu Rev Public Health 23:23–44.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Jones R,
    2. Latinovic R,
    3. Charlton J,
    4. Gulliford MC
    (2007) Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database. BMJ 334(7602):1040.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Cohen RA,
    2. Brown RS
    (2003) Microscopic hematuria. N Engl J Med 348(23):2330–2338.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Hamilton W,
    2. Round A,
    3. Sharp D,
    4. Peters TJ
    (2005) Clinical features of colorectal cancer before diagnosis: a population-based case-control study. Br J Cancer 93(4):399–405.
    OpenUrlCrossRefPubMed
Back to top
Previous ArticleNext Article

In this issue

British Journal of General Practice: 60 (578)
British Journal of General Practice
Vol. 60, Issue 578
September 2010
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Or,
sign in or create an account with your email address
Email Article

Thank you for recommending British Journal of General Practice.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The predictive value of cancer symptoms in primary care
(Your Name) has forwarded a page to you from British Journal of General Practice
(Your Name) thought you would like to see this page from British Journal of General Practice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The predictive value of cancer symptoms in primary care
Kevin Barraclough
British Journal of General Practice 2010; 60 (578): 639-640. DOI: 10.3399/bjgp10X515304

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The predictive value of cancer symptoms in primary care
Kevin Barraclough
British Journal of General Practice 2010; 60 (578): 639-640. DOI: 10.3399/bjgp10X515304
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • Notes
    • REFERENCES
  • Info
  • eLetters
  • PDF

More in this TOC Section

  • Learning disability registers: known unknowns and unknown unknowns
  • Charging for NHS care and its impact on maternal health
  • Helping GPs to diagnose children’s cancer
Show more Editorials

Related Articles

Cited By...

Advertisement

BJGP Life

BJGP Open

 

@BJGPjournal's Likes on Twitter

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Current Issue
  • All Issues
  • Online First
  • Authors & reviewers

RCGP

  • BJGP for RCGP members
  • BJGP Open
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers
  • RCGP e-Portfolio

MY ACCOUNT

  • RCGP members' login
  • Subscriber login
  • Activate subscription
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP: research
  • Writing for BJGP: other sections
  • BJGP editorial process & policies
  • BJGP ethical guidelines
  • Peer review for BJGP

CUSTOMER SERVICES

  • Advertising
  • Contact subscription agent
  • Copyright
  • Librarian information

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7679
Email: journal@rcgp.org.uk

British Journal of General Practice is an editorially-independent publication of the Royal College of General Practitioners
© 2021 British Journal of General Practice

Print ISSN: 0960-1643
Online ISSN: 1478-5242